Skip to main content
. 2022 Aug 1;9:928468. doi: 10.3389/fmed.2022.928468

Table 8.

Adverse events/reactions and their severity levels observed during the trial (SS).

JHQG group Placebo group
Inc. Sub. Rate (%) Inc. Sub. Rate (%)
Adverse events 6 3 2.00 8 4 2.67
Mild 4 2 1.33 2 1 0.67
Moderate 2 1 0.67 6 3 2.00
Severe 0 0 0.00 0 0 0.00
Adverse events that lead to withdrawal 2 1 0.67 4 2 1.33

Inc., incidences; Sub., subjects.